Background: Breast cancer (BrC) is the most frequent neoplasm in women. New biomarkers, including aberrant DNA methylation, may improve BrC management. Herein, we evaluated the detection and prognostic performance of seven genes' promoter methylation (, , , , , and ).

Methods: Methylation levels were assessed in primary BrC tissues by quantitative methylation-specific polymerase chain reaction (QMSP) and in circulating cell-free DNA (ccfDNA) by multiplex QMSP from two independent cohorts of patients (Cohort #1, = 137; and Cohort #2, = 44). Receiver operating characteristic (ROC) curves were constructed, and log-rank test and Cox regression were performed to assess the prognostic value of genes' methylation levels.

Results: The gene-panel , , , discriminated normal from cancerous tissue with high accuracy (95.55%). In multivariable analysis, high -methylation levels [>percentile 75 (P75)] associated with longer disease-free survival, whereas higher -methylation levels (>P75) associated with shorter disease-specific survival. The best performing panel in ccfDNA (, and ) disclosed a sensitivity, specificity and accuracy over 70%.

Conclusions: This approach enables BrC accurate diagnosis and prognostic stratification in tissue samples, and allows for early detection in liquid biopsies, thus suggesting a putative value for patient management.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262630PMC
http://dx.doi.org/10.3390/jcm7110420DOI Listing

Publication Analysis

Top Keywords

breast cancer
8
circulating cell-free
8
cell-free dna
8
-methylation levels
8
dna
4
dna methylation-based
4
methylation-based test
4
test breast
4
cancer detection
4
detection circulating
4

Similar Publications

No evidence that breast cancer occurs at higher rates among young Arab women.

East Mediterr Health J

December 2024

Department of Radiology, King Abdulaziz University, Jeddah, Saudi Arabia.

Article Synopsis
  • The study investigates breast cancer incidence rates among Arab women compared to women from high- and middle-income countries, focusing on age-specific data.
  • Findings reveal that young Arab women have breast cancer rates that are comparable to or lower than those in selected high- and middle-income countries, contradicting the perception of higher risk in this demographic.
  • The results suggest that the higher number of cases in Arab countries may be attributed to a younger population structure, emphasizing the need for updated breast cancer screening policies in the region.
View Article and Find Full Text PDF

In this paper, the pH-sensitive targeting functional material NGR-poly(2-ethyl-2-oxazoline)-cholesteryl methyl carbonate (NGR-PEtOz-CHMC, NPC) modified quercetin (QUE) liposomes (NPC-QUE-L) was constructed. The structure of NPC was confirmed by infrared spectroscopy (IR) and nuclear magnetic resonance hydrogen spectrum (H-NMR). Pharmacokinetic results showed that the accumulation of QUE in plasma of the NPC-QUE-L group was 1.

View Article and Find Full Text PDF

Aim: Dynamic cancer control is a current health system priority, yet methods for achieving it are lacking. This study aims to review the application of system dynamics modeling (SDM) on cancer control and evaluate the research quality.

Methods: Articles were searched in PubMed, Web of Science, and Scopus from the inception of the study to November 15th, 2023.

View Article and Find Full Text PDF

Detection of biomarkers of breast cancer incurs additional costs and tissue burden. We propose a deep learning-based algorithm (BBMIL) to predict classical biomarkers, immunotherapy-associated gene signatures, and prognosis-associated subtypes directly from hematoxylin and eosin stained histopathology images. BBMIL showed the best performance among comparative algorithms on the prediction of classical biomarkers, immunotherapy related gene signatures, and subtypes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!